Quotes 5-day view Delayed Nyse
09/14/2020
09/15/2020
09/16/2020
09/17/2020
09/18/2020
Date
112.72(c)
113.59(c)
114.55(c)
112.59(c)
113.87(c)
Last
764 662
1 112 751
983 174
953 993
1 358 123
Volume
+2.17% +0.77% +0.85% -1.71% +1.14% Change
Sales 2020
8 775 M - -
Net income 2020
1 061 M - -
Net Debt 2020
3 653 M - -
P/E ratio 2020
14,7x
Yield 2020
1,95%
Sales 2021
8 808 M - -
Net income 2021
1 036 M - -
Net Debt 2021
3 428 M - -
P/E ratio 2021
14,9x
Yield 2021
2,03%
Capitalization
15 293 M 15 293 M -
EV / Sales 2020
2,16x
EV / Sales 2021
2,13x
Nbr of Employees
47 000
Free-Float
61,5%
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (95.8%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (4.3%).
Notations Surperformance© of Quest Diagnostics
Trading Rating : Investor Rating :
All news about QUEST DIAGNOSTICS
News in other languages on QUEST DIAGNOSTICS
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends QUEST DIAGNOSTICS
Short Term Mid-Term Long Term Trends Bearish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
18
Average target price
138,13 $
Last Close Price
113,87 $
Spread / Highest target
39,6%
Spread / Average Target
21,3%
Spread / Lowest Target
5,38%
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
